INSP Investors Have Opportunity to Join Inspire Medical Systems, Inc. Fraud Investigation with the Schall Law Firm

Core Viewpoint - The Schall Law Firm is investigating Inspire Medical Systems, Inc. for potential violations of securities laws following a significant drop in share price due to disappointing earnings and operational delays [1][2]. Group 1: Company Performance - Inspire Medical Systems reported Q2 earnings on August 4, 2025, which included a lowered full-year revenue guidance [2]. - The company disclosed delays in the rollout of its "Inspire V" system, as treatment centers postponed adoption due to billing issues with Medicare [2]. - Following the announcement, shares of Inspire fell by almost 40.6% in intraday trading on August 5, 2025 [2]. Group 2: Legal Investigation - The investigation by the Schall Law Firm focuses on whether Inspire issued false or misleading statements or failed to disclose important information to investors [2]. - The firm is representing investors who may have suffered losses and is encouraging them to participate in the investigation [3].